There is a new clinical trial that has just started enrolling adult patients who have been diagnosed with relapsed/refractory Mantle Cell Lymphoma. The study utilizes bendamustine AND retuximab, and provides a viable treatment option for this rare indication.
Please go to http://www.pharmatech.com/practices/open-clinical-trials and click on “Mantle Cell Lymphoma” for details. You can also go to www.clinicaltrials.gov for more info.
Even if this study won't work for some of you, there may be another one that can provide alternative treatment options so keep looking! Be proactive about your treatment and keep open to the possibilities. Good luck to all the fighters out there!
